Search results
Results from the WOW.Com Content Network
NEIMETH International Pharmaceuticals PLC is a publicly listed pharmaceutical company founded in 1997 and headquartered in Lagos. It was established by a former managing director of Pfizer Products of Nigeria to acquire some of the trading assets of Pfizer International in Nigeria.
Desirable policy strategies required for efficient conduct and performance of the industry include better government funding of research and development through the National Institute for Pharmaceutical Research and Development in collaboration with universities, support for the establishment of professional distribution network, completion of ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Lagos: 1982 Bank P A Fidelity Bank Nigeria: Financials Banks Lagos: 1988 Bank P A First Bank of Nigeria: Financials Banks Lagos: 1894 Bank P A Guaranty Trust Bank: Financials Banks Lagos: 1990 Bank P A Industrial and General Insurance Company: Financials Full line insurance Lagos: 1991 Insurance P A Jiji.ng: Technology Internet Lagos: 2014 ...
Multinational companies based in Lagos (2 C, 16 P) Pages in category "Companies based in Lagos" The following 153 pages are in this category, out of 153 total.
Pages in category "Pharmaceutical companies of Nigeria" This category contains only the following page. This list may not reflect recent changes. N. Neimeth PLC
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In 2023, the pharmaceutical companies GlaxoSmithKline and Sanofi ceased their local drug manufacturing, citing various operational challenges. [35] In 2024, amidst a record 27-year high inflation rate of 28.92% and a significant decline in the value of the Naira , [ 36 ] the cost of antibiotics witnessed a more than tenfold increase in price ...